News - Salix Pharmaceuticals

Filter

Current filters:

Salix Pharmaceuticals

Popular Filters

Salix Pharma to combine with unit of Italy’s Cosmo

Salix Pharma to combine with unit of Italy’s Cosmo

09-07-2014

US drugmaker Salix Pharmaceuticals has agreed to combine with an Ireland-based unit of Italy’s Cosmo…

Cosmo PharmaceuticalsCosmo TechnologiesGastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix Pharmaceuticals

Salix leaps on positive Ph III results with Xifaxan in IBS-D

Salix leaps on positive Ph III results with Xifaxan in IBS-D

02-07-2014

US drugmaker Salix Pharmaceuticals’ saw its shares leap as much as 13% after the company released new…

Gastro-intestinalsPharmaceuticalResearchrifaximinSalix PharmaceuticalsXifaxan

Report: Life science companies experience IPO slowdown

10-12-2013

Life sciences companies have been completing fewer initial public offerings (IPOs) this season as the…

Mergers & AcquisitionsPharmaceuticalRocheSalix PharmaceuticalsShireUSA

Salix Pharma moves into diabetes with $2.6 billion buy of Santarus

Salix Pharma moves into diabetes with $2.6 billion buy of Santarus

08-11-2013

Salix Pharmaceuticals has entered into a definitive merger agreement to acquire all the outstanding common…

DiabetesGastro-intestinalsGlumetzaMergers & AcquisitionsPharmaceuticalRare diseasesRuconestSalix PharmaceuticalsSantarus

Opioid-induced constipation market expected to see rapid growth by 2017

Opioid-induced constipation market expected to see rapid growth by 2017

13-10-2013

The global market for opioid-induced constipation will increase significantly from $144.42 million in…

AstraZenecabevenopranCubist PharmaceuticalsEuropeGastro-intestinalsMarkets & MarketingnaloxegolNorth AmericaPharmaceuticalRelistorSalix Pharmaceuticals

FDA approves first anti-diarrheal drug for HIV/AIDS patient, Salix Pharma's Fulyzaq

02-01-2013

Continuing the flurry of 2012 year-end drug approvals, the US Food and Drug Administration on Monday…

crofelemerFulyzaqGastro-intestinalsNapo PharmaceuticalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

FDA action on Salix' crofelemer delayed until 2013

05-09-2012

There was disappointing news for Salix Pharmaceuticals (Nasdaq: SLXP) with the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Salix and Alfa Wassermann expand rifaximin accord

10-08-2012

USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive…

Alfa WassermannGastro-intestinalsLicensingPharmaceuticalRespiratory and PulmonaryrifaximinSalix Pharmaceuticals

US FDA delays Salix' Crofelemer approval

01-05-2012

US drugmaker Salix Pharmaceuticals (Nasdaq: SLXP) revealed yesterday that the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Salix files Crofelemer NDA as spat with Napo moves to Glenmark

15-12-2011

USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalLicensingNapo PharmaceuticalsPharmaceuticalRegulationSalix Pharmaceuticals

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit

09-11-2011

With the aim of improving its innovate products franchise, US drugmaker Salix Pharmaceuticals (Nasdaq:…

FinancialMergers & AcquisitionsOceana TherapeuticsPharmaceuticalSalix Pharmaceuticals

Back to top